Summary
Goodwin is a sponsor of Nature Biotech's SciCafe Series. The topic for the October meeting will be "Genome editing" and partner, Theresa Kavanaugh, will be participating in the panel discussion.
Speakers
- /en/people/k/kavanaugh-theresa
Theresa C. Kavanaugh
Partner
Related Content
- Big Molecule WatchJune 16, 2025
Biosimilar Manufacturers to Expand Offerings in Europe and Japan
- Big Molecule WatchJune 13, 2025
Third Circuit Holds That Granting Discovery Under Section 1782 Is Not a “Final” Judgment
- AlertJune 6, 2025
New Dental Industry Compliance Standards Take Shape: Dental Trade Alliance (DTA) Releases Revised Code of Ethics
- Big Molecule WatchJune 4, 2025
Sandoz Launches PYZCHIVA® (Ustekinumab) Autoinjector in Europe
- Big Molecule WatchJune 3, 2025
Samsung Bioepis Secures Marketing Approval in Korea for its Biosimilar to Amgen’s Bone Cancer Drug Xgeva
- Big Molecule WatchJune 2, 2025
EMA Issues Positive CHMP Opinions for Fresenius Denosumab Biosimilars
- Big Molecule WatchJune 2, 2025
Celltrion, Samsung Bioepis, and Organon Receive Interchangeability Designations for Adalimumab Biosimilars
- AlertJune 2, 2025
State Drug Transparency Laws — 2025 Update
- Events25 June 2025 | 8:30 AM - 10:30 AM BST
Women in the Life Sciences & Healthcare Sector – Breakfast Networking Event
- Press ReleaseJune 13, 2025
Goodwin Guides Deep Apple Therapeutics in Collaboration with Novo Nordisk to Discover and Develop Oral Therapeutics for Cardiometabolic Diseases for up to $812 Million
- In the PressJune 12, 2025
Deals Require Lot More Work Pre-Signing, Says Goodwin; EQT’s Offer for Swedish Software Biz Moves Forward (PE HUB)
- Awards and RankingsJune 11, 2025
The Legal 500 US 2025 Recognizes 44 Goodwin Practices and 172 Lawyers
- In the PressJune 11, 2025
Goodwin Advises GRIN Therapeutics in $50 Million Exclusive Collaboration with Angelini Pharma to Develop and Commercialize Radiprodil Outside North America
- Press ReleaseJune 6, 2025
Goodwin Guides Septerna in Collaboration with Novo Nordisk on Oral Small Molecule Medicines for Obesity and Other Cardiometabolic Diseases for up to $2.2 Billion
- Speaking EngagementsJune 4, 2025
American Conference Institute Inaugural Summit on Life Sciences Cyber, Biosecurity and Data Privacy
- Press ReleaseJune 2, 2025
Blueprint Medicines To Be Acquired By Sanofi For $9.5 Billion Including Contingent Value Rights